Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 14, 1999

View Archived Issues

Disappointing results in colorectal cancer patients treated with ledoxantrone

Sugen speeds development of lead angiogenesis inhibitor

Asta Medica files for approval of LHRH antagonist and establishes marketing partnership

Substance P antagonist reduces pain in dental surgery patients

Human mindin polypeptides and polynucleotides for angiogenic diseases

Licensing opportunity from RCT: VZV subunit vaccine

Mitsubishi sets up marketing network for cholesterol-binding agent; launch anticipated this year

Vanadium complexes claimed by Angiotech for wide range of proliferative disorders

Kyowa Hakko expands R&D activities overseas

Cephalosporin prepared by Korean research team shows promise as lead for further optimization

Toyama, Showa expand periodontitis collaboration

Mechanism of hypoglycemic activity of YM-268 investigated further

Independent panel recommends that pivotal Flocor trial for sickle cell crisis proceed

German academics uncover hormonal mechanism involved in sleep-wake cycles

Provir to be provided to certain AIDS patients in open-label trial

CPMP recommends approval of higher dosage form of Rebif

Telik and Cor Therapeutics enter drug screening and licensing agreement

FDA advisory panel recommends conditional approval of first nonlaser surgical treatment for myopia

Development of cancer treatments targeting apoptosis focus of Idun-Abbott agreement

Extensive toxicity testing conducted on HMG-CoA reductase inhibitor

Medarex and Centeon begin phase II study of MDX-33 as ITP treatment

New antifungal agent approved for marketing in The Netherlands

TKT and Sumitomo collaborate to commercialize Fabry's disease treatment in Asia

Global FluMist collaboration announced by Aviron and Wyeth Lederle Vaccines

Another cancer indication targeted for Genta's G-3139: non-Hodgkin's lymphoma

IntraBiotics begins phase II clinical trial of ramoplanin ointment

Traditional Chinese medicine shows potential as Rx for hypercholesterolemia

Results presented from early clinical study of naked gene transfer as therapy for angina

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...